Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2021-09-22 00:00:00 ET · period of report 2021-09-20 · accession 0001209191-21-057262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-22 | 2021-09-20+ | RCUS | Jarrett Jennifer | COO, Dir | S - Sale | $35.35 | -47.5K | 112.8K | -30% | -$1.68M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-20 | S | D | 600 | $35.67 | 129,709 | D | — | — | (F4) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.60 to $35.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2021-09-20 | S | D | 21,900 | $35.06 | 130,309 | D | — | — | (F3) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.56 to $35.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2021-09-20 | S | D | 8,134 | $35.48 | 152,209 | D | — | — | (F1) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| 4 | Common | Common Stock | 2021-09-21 | S | D | 11,981 | $35.50 | 117,728 | D | — | — | (F5) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.89 to $35.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 5 | Common | Common Stock | 2021-09-21 | S | D | 4,885 | $35.98 | 112,843 | D | — | — | (F6) The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.89 to $36.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |